Conditions: Inflammation Cataract
Keywords: PRO-155 Ocular NSAIDs Safety and tolerability Ocular Inflammation Ocular Paint
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: yes

Brief summary:
Study to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.

Detailed description:
A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.

Arms:
arm 1: Drug: Bromfenac ophthalmic solution 1 drop 4 times per day

Interventions: intervention 1: Bromfenac
Intervention descriptions: intervention 1: Drug: Bromfenac Other names: PRO-155

Protocol document: